SMS Lifesciences India Ltd
BSE: 540679
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 67.83+7.0% | 63.38-21.5% | 80.72+3.7% | 77.84-1.5% | 79.04-7.5% | 85.43+3.1% | 82.88+5.6% | 78.50 |
| Other Income | 0.46-52.9% | 0.97+1136.2% | 0.08-82.0% | 0.44-56.8% | 1.01-54.1% | 2.20+3505.7% | 0.06-95.1% | 1.26 |
| Total Income | 68.29+6.1% | 64.35-20.4% | 80.80+3.2% | 78.28-2.2% | 80.05-8.6% | 87.63+5.7% | 82.94+4.0% | 79.75 |
| EXPENSES | ||||||||
| Expenditure | 63.01+3.0% | 61.18-16.6% | 73.31+2.9% | 71.23-1.8% | 72.57-13.9% | 84.29+13.4% | 74.33+4.4% | 71.19 |
| Tax | 2.04+116.1% | 0.94-54.7% | 2.08+0.5% | 2.07-10.8% | 2.32+252.1% | 0.66-72.3% | 2.38-6.7% | 2.55 |
| PROFIT | ||||||||
| PBT | 5.28+66.0% | 3.18-57.6% | 7.49+6.2% | 7.05-5.8% | 7.48+124.3% | 3.33-61.3% | 8.61+0.6% | 8.56 |
| Net Profit | 3.24+44.9% | 2.23-58.7% | 5.41+8.6% | 4.98-3.5% | 5.16+92.8% | 2.68-57.0% | 6.23+3.7% | 6.01 |
| KEY METRICS | ||||||||
| OPM % | 14.22%+4.44pp | 9.78%-4.54pp | 14.32%+0.45pp | 13.87%+0.16pp | 13.71%+7.16pp | 6.55%+1.69pp | 4.86%+1.28pp | 3.58% |
| NPM % | 4.74%+1.27pp | 3.47%-3.22pp | 6.69%+0.33pp | 6.36%-0.08pp | 6.44%+3.39pp | 3.05%-4.46pp | 7.51%-0.02pp | 7.53% |
| EPS | 10.71+44.9% | 7.39-58.7% | 17.88+8.6% | 16.46-3.5% | 17.06+92.8% | 8.85-57.0% | 20.60+3.7% | 19.87 |
Corporate Events
Board MeetingHALEOSLABS
202630Sep
Board Meeting
The 20th Annual General Meeting (AGM) of the company is sche…
BSE Filing ↗ Board MeetingHALEOSLABS
20265Aug
Board Meeting
The meeting of the Board of Directors of the Company has bee…
BSE Filing ↗ Board MeetingHALEOSLABS
202629May
Board Meeting
The board meeting is scheduled to consider and approve the a…
BSE Filing ↗ Board MeetingHALEOSLABS
202427May
Board Meeting
Consider and approve audited financial results (Standalone a…
BSE Filing ↗ Board MeetingHALEOSLABS
202311Nov
Board Meeting
consider and approve the unaudited financial results (Standa…
BSE Filing ↗ Board MeetingHALEOSLABS
20238Aug
Board Meeting
Consider and approve Unaudited Financial Results (Standalone…
BSE Filing ↗